Drug commonly used as antidepressant helps fight cancer in mice
A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the…
Browsing: Immunotherapy
Protein disguise could be new target for cancer immunotherapy
Researchers at the Francis Crick Institute, UK, have identified a protein that helps tumours evade…
Immunotherapy after surgery reduces deadly relapse risk in advanced bladder cancer
A phase 3 clinical trial co-led by Mount Sinai researchers in the USA is the…
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer
In a presentation of real-world data, researchers from Fox Chase Cancer Center, USA, have concluded…
ASCO 2021: Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma
Patients with high-risk melanoma who had a course of pembrolizumab after their surgery had a…
ASCO 2021: Both single and dual immunotherapy regimens offer improved overall survival for select patients with advanced oesophageal cancer
“Certain patients with advanced oesophageal cancer, who currently have few treatment options, now stand to…
ASCO 2021: Post-surgery immunotherapy extends disease-free survival for select patients with kidney cancer
Immunotherapy after surgery significantly improved disease-free survival (DFS) for patients with the most common type…
ASCO 2021: Addition of immunotherapy to standard of care first-line regimen delays disease progression in advanced nasopharyngeal carcinoma
The addition of the immunotherapy agent toripalimab to standard first-line chemotherapy significantly delayed disease progression…
ASCO 2021: Choice of first-line platinum regimen does not significantly impact efficacy of second-line IO in advanced bladder cancer
In a presentation of real-world data, researchers from Fox Chase Cancer Center, USA, have concluded…
ASCO 2021: Benefits of immunotherapy combination persist for more than six years in advanced melanoma
In the longest follow-up results from a clinical trial of combination immunotherapy for metastatic melanoma,…